UK markets closed

Cardinal Health, Inc. (CAH)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
94.10-0.36 (-0.38%)
At close: 04:00PM EDT
94.02 -0.08 (-0.09%)
After hours: 04:39PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 23.01B
Enterprise value 25.14B
Trailing P/E 41.80
Forward P/E 12.53
PEG ratio (5-yr expected) 0.28
Price/sales (ttm)0.11
Price/book (mrq)N/A
Enterprise value/revenue 0.11
Enterprise value/EBITDA 14.83

Trading information

Stock price history

Beta (5Y monthly) 0.62
52-week change 31.42%
S&P500 52-week change 323.95%
52-week high 3116.04
52-week low 385.12
50-day moving average 398.85
200-day moving average 3102.31

Share statistics

Avg vol (3-month) 32.11M
Avg vol (10-day) 32.17M
Shares outstanding 5243.57M
Implied shares outstanding 6243.57M
Float 8242.4M
% held by insiders 10.58%
% held by institutions 191.39%
Shares short (28 Jun 2024) 46.12M
Short ratio (28 Jun 2024) 42.71
Short % of float (28 Jun 2024) 43.35%
Short % of shares outstanding (28 Jun 2024) 42.51%
Shares short (prior month 31 May 2024) 46.87M

Dividends & splits

Forward annual dividend rate 42.02
Forward annual dividend yield 42.14%
Trailing annual dividend rate 32.00
Trailing annual dividend yield 32.12%
5-year average dividend yield 43.17
Payout ratio 488.60%
Dividend date 315 Jul 2024
Ex-dividend date 401 Jul 2024
Last split factor 23:2
Last split date 323 Apr 2001

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 0.25%
Operating margin (ttm)1.07%

Management effectiveness

Return on assets (ttm)2.92%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)220.57B
Revenue per share (ttm)891.20
Quarterly revenue growth (yoy)8.80%
Gross profit (ttm)N/A
Net income avi to common (ttm)552M
Diluted EPS (ttm)2.26
Quarterly earnings growth (yoy)-25.20%

Balance sheet

Total cash (mrq)3.72B
Total cash per share (mrq)15.27
Total debt (mrq)5.85B
Total debt/equity (mrq)N/A
Current ratio (mrq)0.98
Book value per share (mrq)-13.38

Cash flow statement

Operating cash flow (ttm)2.54B
Levered free cash flow (ttm)1.67B